Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Respiratory & allergyPRM 1452
Dosage formSyrup
Oral

Acebrophylline 10 mg

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 890
Respiratory & allergyPRM 2146
Dosage formHard-gelatin capsules
Oral

Acebrophylline 100 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 153
Respiratory & allergyPRM 0026
Dosage formTablets
Oral

Acebrophylline 100 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0028
Dosage formTablets
Oral

Acebrophylline 100 mg, N-Acetylcysteine 600 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2147
Dosage formHard-gelatin capsules
Oral

Acebrophylline 200 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0027
Dosage formTablets
Oral

Acebrophylline 200 mg (SR) Film Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 109
Respiratory & allergyPRM 2592
Dosage formTablets
Oral

Acebrophylline 200 mg (SR), Desloratadine 5 mg, Montelukast 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Leukotriene receptor antagonist + Xanthine bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2593
Dosage formTablets
Oral

Acebrophylline 200 mg (SR), Fexofenadine 120 mg, Montelukast 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Leukotriene receptor antagonist + Xanthine bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0031
Dosage formTablets
Oral

Acebrophylline 200 mg (SR), Montelukast 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Leukotriene receptor antagonist
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1662
Dosage formOral suspension
Oral

Acebrophylline 50 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Respiratory & allergy agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1454
Dosage formSyrup
Oral

Acebrophylline 50 mg, Guiphenesin 50 mg, Terbutaline 1.25 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1453
Dosage formSyrup
Oral

Acebrophylline 50 mg, Menthol 2.5 mg, Terbutaline 1.25 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1792
Dosage formLiquid injectables
Parenteral

Acetylcysteine 1000 mg / 5 ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0063
Dosage formTablets
Oral

Acetylcysteine 300 mg, Pyridoxine 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1793
Dosage formLiquid injectables
Parenteral

Acetylcysteine 400 mg / 2 ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1072
Dosage formTablets
Oral

Acetylcysteine 50 mg, Biotin 10 mg, Calcium Pantothenate 100 mg, Cupric Oxide 3 mg, Sodium Selenite 65 mg, Zinc Oxide 22.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0064
Dosage formTablets
Oral

Acetylcysteine 600 mg, L-Methyl Folate Calcium 5.6 mg, Methylcobalamin 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4628
Dosage formHard-gelatin capsules
Oral

Acrivastine 8 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5181
Dosage formSyrup
Oral

Alcohol 0.2625 ml, Alcohol Content 5% v/v, Ammonium Chloride 0.138 gm, Diphenhydramine Hcl 14.08 mg, Menthol 1.14 mg, Sodium Citrate 57.03 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Expectorant + H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4675
Dosage formHard-gelatin capsules
Oral

Alprazolam 0.25 mg, Pseudoephedrine Hcl 120 mg (SR)

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Adrenergic decongestant + Benzodiazepine anxiolytic / anticonvulsant
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 1458
Dosage formSyrup
Oral

Ambroxol 15 mg, Ammonium Chloride 60 mg, Guaifenesin 50 mg, Menthol 1 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0113
Dosage formTablets
Oral

Ambroxol 15 mg, Cetirizine 5 mg, Guaifenesin 100 mg, Paracetamol 325 mg, Phenylephrine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class III (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 0114
Dosage formTablets
Oral

Ambroxol 15 mg, Cetirizine 5 mg, Guaifenesin 50 mg, Paracetamol 325 mg, Phenylephrine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class III (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5185
Dosage formSyrup
Oral

Ambroxol 15 mg, Chlorpheniramine Maleate 2 mg, Dextromethorphan Hbr 10 mg, Menthol 1.5 mg, Phenylephrine 5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Adrenergic decongestant + Antitussive + H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product